Section Arrow
ANIK.NASDAQ
- Anika Therapeutics
Quotes are at least 15-min delayed:2025/05/10 09:00 EDT
Last
 11.64
-3.1 (-21.03%)
Day High 
13.3 
Prev. Close
14.74 
1-M High
15.13 
Volume 
222.17K 
Bid
4.7
Ask
18.76
Day Low
11.48 
Open
12.79 
1-M Low
12.83 
Market Cap 
211.39M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 14.53 
20-SMA 14.21 
50-SMA 15.12 
52-W High 29.115 
52-W Low 11.48 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.83/0.39
Enterprise Value
235.41M
Balance Sheet
Book Value Per Share
10.74
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
119.91M
Operating Revenue Per Share
11.39
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SHPHShuttle Pharmaceuticals Holdings Inc0.2325-0.0375-13.89%-- 
PTPIPetros Pharmaceuticals Inc0.1201-0.0053-4.23%-- 
VTRSViatris8.77-0.32-3.52%227.2PE
TEVATeva Pharmaceutical Industries Limited16.93-1.14-6.31%-- 
IXHLIncannex Healthcare0.1135+0.0009+0.80%-- 
Quotes are at least 15-min delayed:2025/05/10 09:00 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.